How is laboratory monitoring of persons on LT4 therapy different from patients who are taking combination therapy with a DTE? Do you need to monitor T3 in patients on DTE? What should you be observing with respect to symptomatic improvement?

How is laboratory monitoring of persons on LT4 therapy different from patients who are taking combination therapy with a DTE? Do you need to monitor T3 in patients on DTE? What should you be observing with respect to symptomatic improvement?

How is laboratory monitoring of persons on LT4 therapy different from patients who are taking combination therapy with a DTE? Do you need to monitor T3 in patients on DTE? What should you be observing with respect to symptomatic improvement?


Created by

CMEducation Resources IQ&A Thyroid Hormone Replacement Medical Intelligence Zone

Presenter

Christine Kessler, MN, ANP-BC, CNS, BC-ADM, FAANP

Christine Kessler, MN, ANP-BC, CNS, BC-ADM, FAANP

Founder, Nurse Practitioner Metabolic Medicine AssociatesCo-Chair, Metabolic & Endocrine Disease Summit (MEDS) King George, Virginia